RxDoctor Payments Data

Bernard Bochner, MD

Urology · New York, NYNPI 1558347161

Payments from drug & device makers

What this record shows

This record is dominated by education: $67,066 of the $83,254 with a category attached, or 80.6%. Olympus Corporation Of The Americas accounts for 84.7% of it on its own, with 11 other manufacturers making up the rest. Among urology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$83,254in general payments, 2019–2025

Across 129 payments — averaging $645.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$70K
  • Janssen Scientific Affairs, LLC$4K
  • Astellas Pharma US Inc$2K
  • Olympus Winter & Ibe GmbH$2K
  • Johnson & Johnson$1K
  • Olympus Corporation$1K
  • plus $2K from 6 others

What the payments were for

  • Consulting fees$9,04011%
  • Speaking & faculty fees$1,4852%
  • Travel & lodging$3,8315%
  • Food & beverage$1,8322%
  • Education$67,06681%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,254 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024
$347,718
Medicare patients
767
Services billed
2,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl37$338
Finasteride13$291
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$90
Ciprofloxacin Hcl15$57
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$33
Amoxicillin14$33

Paid to pharmacies, not to this prescriber.

Other urology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →